SS Innovations International (SSII) Return on Capital Employed (2017 - 2026)
SS Innovations International (SSII) posted Return on Capital Employed of 10.85% for Q1 2026, up 41.0% sequentially from 18.39% in Q4 2025, and up 2888.0% YoY from 0.36% in Q1 2025.
SS Innovations International (SSII) Return on Capital Employed (2017 - 2026) Analysis & Trends
SS Innovations International has reported Return on Capital Employed for 10 years, with the latest figure at 10.85% in Q1 2026.
- Quarterly Return on Capital Employed rose 2888.0% year-over-year to 10.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.85% (up 2888.0% YoY) and the FY2025 annual result came in at 25.56%, up 9593.0% from the prior year.
- Return on Capital Employed climbed to 10.85% in Q1 2026 per SSII's latest filing, from 18.39% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 449.97% in Q3 2022 and troughed at 1549.84% in Q2 2022.
- A 5-year average of 236.35% and a median of 94.91% in 2023 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 163639 bps in 2022, down 170485 bps in 2022.
- Over 5 years, Return on Capital Employed stood at 61.07% in 2022, then plunged by 255 bps to 94.91% in 2023, then fell by 3 bps to 97.95% in 2024, then jumped by 81 bps to 18.39% in 2025, then surged by 41 bps to 10.85% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 10.85%, 18.39%, and 19.55% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn | -13.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.71% |
| Mar 31, 2026 | -10.85% |
| Dec 31, 2025 | -18.39% |
| Sep 30, 2025 | -19.55% |
| Jun 30, 2025 | -23.07% |
| Mar 31, 2025 | -39.73% |
| Dec 31, 2024 | -97.95% |
| Sep 30, 2024 | -155.46% |
| Jun 30, 2024 | -136.61% |
| Mar 31, 2024 | -142.85% |
| Dec 31, 2023 | -94.91% |
| Sep 30, 2023 | -76.25% |
| Jun 30, 2023 | -827.05% |
| Mar 31, 2023 | -280.50% |
| Dec 31, 2022 | 61.07% |
| Sep 30, 2022 | 449.97% |
| Jun 30, 2022 | -1,549.84% |
| Mar 31, 2022 | -1,056.08% |
| Dec 31, 2021 | -1,575.32% |
| Sep 30, 2021 | 152.16% |